Implantable devices with invasive and non-invasive reversible infusion rate adjustability

• US 20040015154A1
• Filed: 03/11/2003
• Published: 01/22/2004
• Est. Priority Date: 04/19/2001
• Status: Abandoned Application

• Current Assignee: Microsolutions Incorporated
• Original Assignee: Microsolutions Incorporated
• Inventors: Milo, Charles F., Harper, Derek J.
• Application Number:
  US10/386,919
• Publication Number:
  US 20040015154A1
• Time in Patent Office: Days
• US Class Current: 604/892.1
• CPC Class Codes: A61M 2005/14513 with secondary fluid driving or regulating the infusion
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61M 5/14526 the piston being actuated by fluid pressure
• CPC Class Codes: A61M 5/16877 Adjusting flow; Devices for setting a flow rate

Abstract

An implantable pump for delivering a pharmaceutical agent includes a pump engine, a piston, a pharmaceutical agent compartment and a rate adjustment assembly. The pharmaceutical agent compartment is configured to enclose a volume of pharmaceutical agent and the piston. When the piston is acted upon by the pump engine, the piston moves within the pharmaceutical agent compartment along a substantially circular path and delivers the pharmaceutical agent. The rate adjustment assembly is configured to enable a selective and reversible increase or decrease of the delivery rate of the pharmaceutical agent.

Claims

1. A pump for delivering a pharmaceutical agent, comprising:

a pump engine;

a piston;

a pharmaceutical agent compartment configured to enclose a volume of pharmaceutical agent and the piston, the pharmaceutical agent compartment being configured such that when the piston is acted upon by the pump engine, the piston moves within the pharmaceutical agent compartment and delivers the pharmaceutical agent, and

a rate adjustment assembly configured to enable a selective and reversible increase or decrease of a delivery rate of the pharmaceutical agent.

2. The pump of claim 1, wherein the rate adjustment assembly is configured to selectively vary the delivery rate of the pharmaceutical agent by percutaneous insertion and manipulation of a rate adjustment tool in the rate adjustment assembly.

3. The pump of claim 1, wherein the rate adjustment assembly is configured to vary the delivery rate of the pharmaceutical agent non-invasively when the pump is implanted into a patient.

4. The pump of claim 1, wherein the rate adjustment module is configured to enable the delivery rate of the pharmaceutical agent to be changed by application of an external magnetic field to the pump.

5. The pump of claim 1, wherein the pharmaceutical agent compartment is preloaded with the volume of the pharmaceutical agent.

6. A method of delivering a pharmaceutical agent, comprising steps of:

implanting a pump into the patient, the pump including a pump engine, a piston, a pharmaceutical agent compartment configured to enclose a volume of pharmaceutical agent and the piston, the pharmaceutical agent compartment being configured such that when the piston is acted upon by the pump engine, the piston moves within the pharmaceutical agent compartment and delivers the pharmaceutical agent, and a rate adjustment assembly configured to enable a selective and reversible increase or decrease of a delivery rate of the pharmaceutical agent;

manipulating the rate adjustment assembly to selectively increase or decrease the delivery rate of the pharmaceutical agent.

7. The method of claim 6, wherein the implanting step includes a step of making an incision in the patient near a desired implantation site and wherein the manipulating step is carried out after the implantation step and after the incision is closed.

8. The method of claim 7, wherein the manipulation step includes a step of percutaneously inserting a rate adjustment tool into the rate adjustment assembly.

9. The method of claim 7, wherein the manipulation step is carried out without breaching the patient'"'"'s skin.

10. The method of claim 7, wherein the manipulation step includes a step of applying an external magnetic field near the implantation site.

11. The method of claim 10, wherein the external magnetic field applying step includes a step of rotating the external magnetic field by a selected degree of rotation.

12. An osmotic pump, comprising:

an osmotic engine;

a pump housing enclosing the osmotic engine and defining a space adapted to contain a volume of pharmaceutical agent, and

a rate adjustment module configured to enable a selective and reversible increase or decrease of a delivery rate of the pharmaceutical agent.

13. The osmotic pump of claim 12, wherein the space is preloaded with the volume of the pharmaceutical agent.

14. An osmotic pump for delivery a pharmaceutical agent, comprising:

an osmotic engine;

a pharmaceutical agent compartment adapted to contain a volume of the pharmaceutical agent;

a plurality of semipermeable membranes, one end of each of which being in communication with the osmotic engine, each of the plurality of semipermeable membranes being configured to enable an osmotic pressure differential to develop when another end thereof is selectively exposed to fluid from an environment of use, and

a rate adjustment assembly configured to selectively expose or cover at least one of the plurality of semipermeable membranes to the environment of use to selectively and reversibly increase or decrease a rate at which the pharmaceutical agent is delivered from the osmotic pump.

15. The osmotic pump of claim 14, wherein the rate adjustment module is configured to enable the selective and reversible increase or decrease of the delivery rate without direct physical contact with the pump.

16. The osmotic pump of claim 14, wherein the rate adjustment module is configured to enable the selective and reversible increase or decrease of the delivery rate through an application of an external magnetic field to the osmotic pump.

17. The osmotic pump of claim 14, wherein the rate adjustment assembly is further configured to mate with a rate adjustment tool.

18. The osmotic pump of claim 14, wherein the pharmaceutical agent compartment is preloaded with the volume of the pharmaceutical agent.

19. A method of non-invasively increasing or decreasing a dose of pharmaceutical agent delivered to a patient by a previously implanted osmotic pump, comprising the steps of:

providing a magnet;

positioning the provided magnet on or close to a skin of the patient over the previously implanted osmotic pump, and

rotating the positioned magnet by a predetermined degree of rotation, whereby the implanted osmotic pump responds to the rotating magnet by increasing or decreasing the dose of pharmaceutical agent delivered to the patient.